MedEdge Solutions, Sphinx Strategies launch partnership to boost pharmacy growth

INDIANAPOLIS – MedEdge Solutions and Sphinx Strategies have announced a strategic partnership, named Protocol to Proof, to power growth into new therapies and business lines for specialty and infusion pharmacies, and to strengthen business development across the industry as a whole. "Growth in this market has always been rationed by talent," said Brandon Carpenter, CEO and founder of MedEdge Solutions. "Every new therapy or line of business demands two scarce skill sets at once: the people who can get you licensed and contracted, and the people who can shoulder the data obligations that begin the moment you go live. Very few organizations can recruit and retain both simultaneously. That constraint is now gone. Sphinx executes the launch, MedEdge validates and automates the associated data intelligence, and the operator is free to scale." The companies say the partnership takes aim at the constraint that limits growth for nearly every independent operator in this market: expanding into a new therapy or business line requires proving you can both launch it correctly – accreditation, licensure, payer contracting, clinical readiness – and deliver the data that follows it, and almost nobody can staff for both. Sphinx will cover clinical program design and compliance, operational workflow and staff readiness, business development, payer and PBM contracting, licensure strategy, accreditation and certification readiness, and patient access. MedEdge will locate the data inside the systems these organizations already run, validating it against manufacturer, payer and program rules, resolving exceptions before anything moves and automating delivery to every party that requires it.